Introduction
Patient-centered medicine (i.e., care in which the doctor responds to the patients' needs, including their thoughts or feelings), is a recent a buzz-word [1] .
This concept became most popular after its comprehensive description by Brown and co-workers in 1995 [2] when identified several interconnecting components which included the enhancement of doctor-patient relationships. It is also increasingly evident that patients want to be fully informed and be part of the treatment decision making. They have a better idea of their requirements, and are able to verbalize their needs and preferences when they are invited to do so [3] . There is evidence that informed patients are better aware of matters relating to their care and therefore they should also be better placed to take an active part in their own care [4] and improve the quality and responsiveness of health care services. Nevertheless, to our knowledge, no sufficient attention has been paid to the patients' perspectives on the sources they use to obtain information on genetic disorders.
HH is one of the most common adult-onset genetic disorders in European-derived populations [5] . It is a chronic disorder which occurs when the normal regulation of iron absorption is disrupted resulting in the accumulation of excessive iron in the liver, pancreas, heart and joints leading to organ damage, and impaired function [6] . In spite of being a potentially lethal disease, early diagnosis of HH and treatment by venesections can restore normal life expectancy, reduce symptoms, and help to prevent organ damage [7] . In contrast, failure to detect HH increases the likelihood that irreversible adverse health effects will occur and increases the future financial burden associated with health care for persons with HH [8] . These findings have led to recommendations for increased case detection and universal screening using phenotypic testing (eg, transferrin saturation) to permit early treatment before the onset of clinical disease [9] . Moreover, taking into Page 5 of 25 A c c e p t e d M a n u s c r i p t 5 consideration the healthy status of early diagnosed HH carriers, the potential use of their blood for transfusion is nowadays an issue of major interest [10] .
Early detection and treatment of HH depends on increased awareness and proper information among health professionals and patients themselves, who play an important role in the motivation and spread of information among their relatives. In spite of these recommendations, much of the literature suggests that HH is still largely underdiagnosed and therefore undertreated [11] [12] [13] , a position that was also recognized by the European Commission in response to a parliamentary question promoted by the European Federation of Patients with Haemochromatosis (EFAPH) (E-012656/2011).
In general, there is a paucity of information about the patients' perceptions about HH and, to our knowledge, no studies have ever been performed regarding the sources of information they find useful [8, 14] . This is particularly relevant in Europe where, in spite of a low clinical penetrance, the genetic condition is highly prevalent [5] . That question was addressed in this study in which members of nine patients' associations were invited to participate in an international survey online. The survey was designed to understand which sources are used by patients or subjects at risk to find information about HH, where do they prefer to get it from, where they would like to find it, and which information sources they trust more.
Our expectation is that the results of this study will be useful for the implementation of new strategies on HH awareness and consequently may contribute to increase early diagnosis of the disease.
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The questionnaire
Members from nine National Associations of Patients with Haemochromatosis, all EFAPH members, (France, Germany, Hungary, Italy, Ireland, Netherlands, Norway, Portugal and United Kingdom) were enrolled in the present study regarding genetic testing and the sources of information used to find information about HH. They were invited to answer to a survey posted online by EFAPH, using the SurveyMonkey platform.
The survey online was preferred as a suitable and economical method for data collection because our target population was large and our measurements focused on patients' own perceptions [15] . A copy of the survey is available from the authors upon request.
Because this is the first survey of its kind, there was no available a priori information to guide our strategy to identify the sources of information usually used by the associations' members. Therefore various steps were taken to ensure the validity and reliability of the study. Initially, the study design was evaluated by a committee The cover page of the questionnaire explained the objective of the study and contained elements of informed consent (including an opt-out option), so that participants only answered the survey after acceptance of the conditions.
Data collection, sampling and contents
Data were mostly obtained from the electronic version of the survey, but in two cases (Germany and Portugal) the questionnaires were sent by post to the coordinator who then transferred the data to the SurveyMonkey platform. The local coordinator was also responsible for the translation of the answers. Demographic data were collected in order to characterize the sample, including gender, age, nationality, years of education and occupation. The respondents' answers about age were displayed as six categories 
Analysis
We computed descriptive statistics (means, standard deviations, and proportions) of the variables and examined the distributions of the responses. Differences in distributions were analyzed by the Chi-Square test with IBM SPSS Statistics 19.
Ethics
The basic principles of research ethics were followed at all stages of the study. All the data were handled confidentially according to the principles stated in the Helsinki Declaration [18] . M a n u s c r i p t 9
Results
Three thousand nine hundred and seventy three members were invited to participate and 1032 (26%) answered the questionnaire. From the total population of 1032 respondents, 13 were excluded because they had supplied only partial replies to demographic questions and did not proceed with the questionnaire. In addition, 124 respondents had not had a genetic test and were therefore excluded from the analyses. The remaining 895 respondents who declared to have performed a genetic test were considered for further analyses. A schematic representation of sample collection and processing is given in Figure 1 . The average age of respondents was 55. 7 + 11.7 years (mean + standard deviation), 58% were males and 42% were female. Thirty eight percent of the participants were graduates and 30% of the participants were included in major group 2, Professionals, and 21% of total number of participants were retired. The distribution of participants by nationality is recorded in Table 1 .
When asked if they "feel sufficiently informed about your genetic testing and its implications to your health?" 70% answered "yes" and 30% answered "no". The respondents that felt sufficiently informed were aged between 55-65 years and the respondents that did not feel sufficiently informed were 45-55 years old.
Regarding the respondents that answered "yes" to the above question, when asked "where did you get information?", the majority reported that their main source of information was the specialist (66%), 39% referred to the family doctor and 38% to Patients Associations (Table 2 and Fig. 2 ). When data were analyzed by National Associations we observed that they all obtained information mainly from the specialist, except the participants from Irish Haemochromatosis Society, who obtained information mainly from their family doctors.
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When asked "where would you like to find information?", a higher percentage expressed a preference for obtaining information from the family doctor (66%), while a lower percentage preferred the specialist (59%) or the patient association (44%) ( Table 2 and Fig. 2) . Nevertheless, when asked "Of those sources of information, in which do you trust more?" the majority mentioned the specialist (69%) followed by the Patient Association (41%) or the family doctor (31%) ( Table 2 and Fig. 2 ).
Regarding the respondents who answered "no" to the question "Do you feel sufficiently informed about your genetic testing and its implications to your health?", the majority preferred to obtain information from their family doctor (78%), closely followed by a specialist (77%), with the third preference being official websites on the internet (53%) ( Table 2 and Fig. 3 ). Such as in the case of informed participants, these also trusted more in the specialist (75%), rather than the family doctor (35%) or Patient Association (24%) ( Table 2 and Fig. 3 ).
We also asked the participants if they "feel sufficiently informed about the implications of your genetic testing to other family members": 78% answered "yes" and 22% answered "no".
Of the respondents who answered "yes" to the question above, when asked "where did you get information?", the majority reported that their main source of information was the specialist (72%). The specialist was also the preferred source (69%) and whom they trusted more (68%) ( Table 3) .
Of the respondents who answered "no" to the question "Do you feel sufficiently informed about the implications of your genetic testing to other family members" 77% stated that they would like to obtain the information from the specialist and 72% had more trust in the specialist (Table 3) Results of the questionnaire revealed that 70% of respondents reported that they felt sufficiently informed about genetic testing and its implications to their health.
However, a lower percentage (55%) that they were sufficiently informed about the implications to their family members.
The results reveal that respondents would like to receive more information about HH from the family doctor, despite having more trust in the specialist. This highlights the importance of targeting GPs as an important requested source of information. This is not surprising, since it had been already reported that about half of HH diagnoses are performed by a gastroenterologist, a hematologist and some other specialist physician, as opposed to being diagnosed by a primary care provider [14] . A recent study in Australia [7] showed that of 80% of GPs who reported that they had patients with HH, only 41% managed the condition primarily.
Page 12 of 25
12
The participants from Irish Haemochromatosis Society were the only ones who answered that they obtained information about genetic testing mostly from the family doctor. This is interesting and probably reflects a commitment of GPs in Ireland to promote the diagnosis, treatment and management of patients with HH in the Primary Care Setting, in collaboration with the Irish Haemochromatosis Association [19] . This could also reflect the very high frequency of HH encountered by GPs in Ireland compared to those in other countries where the disease is not so common. As the GPs in Ireland have more cases of patients with HH they are more informed about the disease and thus their patients receive better treatment.
The results showed that participants also used the internet as a source of information. We are aware that web-based information is a valuable resource for patients with many conditions although its reliability and quality have been questioned [20] . This is reflected in the results by the fact that a higher number of respondents selected official internet official websites rather than other websites. It is important to note that healthcare professionals have an important role in evaluating websites and directing patients and care givers to sites which provide accurate and up-to-date information [21] .
In this study the respondents also recognized the specialists' relevance in transmitting the information about genetic testing implications to other family members.
In a recent study, Leandro and co-workers reported a general lack of knowledge about the selection of patient cases that should be sent for genetic counseling or for molecular testing of HFE-HH by physicians [22] . The lack of a primordial family-based screening may indirectly compromise the efficiency of disease prevention in terms of early diagnosis and treatment. A partnership between genetic counselors, medical geneticists, and primary care providers is also essential in order to develop effective policies,
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Limitations
The fact that a high proportion of participants felt sufficiently informed can be explained by them being members of Patient Associations and thus being more motivated to find information about the disease. It could be suggested that this is a limitation of the study as it does not necessarily reflect the degree of awareness of HH population in general, eventually compromising the results' generalization. However, we felt that by targeting an already informed population we could identify more effectively the focus of future actions to increase awareness about HH.
The response rate was not as high as desired and this might limit the generalization of the results. Nevertheless, the Patient Associations' members proved to be a good target population in terms of motivation, participation and geographic diversity. In addition, this study was able to identify some opportunities for stimulating and improving cooperation between associations and to create a feeling amongst the participants of the study that they are making an active contribution to the activities of their own associations.
Conclusion
In conclusion, the present study clearly identified the General Practitioner as being the preferred source for delivering specific information to HH patients about the disease and its implications to their health. M a n u s c r i p t 14
Practice Implications
According to Acton [24] many physicians have an inadequate knowledge about HH diagnosis and the results reinforce the importance of GPs as a source of information about HH. Consequently these results may have important applications in future strategies for increasing awareness of the disease.
We confirm that all patient/personal identifiers have been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of this report.
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